Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple, non-specific microbial and host thiol-containing molecules and pathways refer to a broad class of biological entities characterized by the presence of reactive sulfhydryl (-SH) groups. These molecules, which include low-molecular-weight thiols like glutathione and mycothiol as well as cysteine residues in proteins, are essential for maintaining cellular redox homeostasis and enzymatic activity (Source 1.2.2, 1.2.5). Drugs that target these groups, such as silver compounds, disulfiram, and heavy metals, typically act by covalently binding to or oxidizing the thiols, which leads to protein denaturation and the collapse of microbial metabolism (Source 1.2.1, 1.2.3). While this non-specific mechanism provides potent broad-spectrum antimicrobial activity, it also poses a significant risk of host toxicity because human cells rely on similar thiol-dependent pathways for survival (Source 1.2.5). Consequently, these targets are most commonly exploited in topical antiseptics or in specific therapeutic contexts where the drug's distribution can be carefully managed. Understanding the complex interactions between drugs and the thiol-rich environment of both pathogens and hosts is critical for optimizing efficacy and minimizing adverse systemic effects (Source 1.2.4).
Covalent modification, oxidation, or coordination binding to sulfhydryl (-SH) groups, leading to the inactivation of essential enzymes, depletion of cellular antioxidant capacity (e.g., glutathione), and disruption of metabolic and signaling pathways.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple, non-specific microbial and host thiol-containing molecules and pathways.